Ziopharm Oncology (ZIOP) Reports Q3 Loss of $0.14/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
Loss from operations: -10.91M
Today's EPS Names:
IEP, XPRO, GEF, More
Financial Fact:
Loss from operations: -10.91M
Today's EPS Names:
IEP, XPRO, GEF, More
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q3 EPS of ($0.14), versus ($0.06) reported last year.
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADTRAN, Inc. (ADTN) Tops Q3 EPS by 5c; offers guidance
- Ero Copper Corp. (ERO) Tops Q3 EPS by 14c
- Ryman Hospitality Properties (RHP) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
